Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J
Curr Oncol. 2025; 32(1).
PMID: 39851951
PMC: 11763369.
DOI: 10.3390/curroncol32010035.
Lopez-Terrada D, Stahlschmidt J, Perez-Atayde A
Virchows Arch. 2025; 486(1):23-47.
PMID: 39836187
DOI: 10.1007/s00428-024-03985-4.
Wang W, Du Y, Datta S, Fowler J, Sang H, Albadari N
Genes Dis. 2025; 12(2):101156.
PMID: 39802403
PMC: 11719324.
DOI: 10.1016/j.gendis.2023.101156.
Yu X, Sarabia S, Urbicain M, Somvanshi S, Patel R, Tran T
bioRxiv. 2025; .
PMID: 39763896
PMC: 11703271.
DOI: 10.1101/2024.12.24.630261.
Requena D, Medico J, Soto-Ugaldi L, Shirani M, Saltsman 3rd J, Torbenson M
Nat Commun. 2024; 15(1):10887.
PMID: 39738196
PMC: 11685927.
DOI: 10.1038/s41467-024-55238-2.
Characterization of an Activated Metabolic Transcriptional Program in Hepatoblastoma Tumor Cells Using scRNA-seq.
Monge C, Frances R, Marchio A, Pineau P, Desterke C, Mata-Garrido J
Int J Mol Sci. 2024; 25(23).
PMID: 39684755
PMC: 11641740.
DOI: 10.3390/ijms252313044.
Single-Cell RNA-Seq Analysis Links DNMT3B and PFKFB4 Transcriptional Profiles with Metastatic Traits in Hepatoblastoma.
Desterke C, Frances R, Monge C, Marchio A, Pineau P, Mata-Garrido J
Biomolecules. 2024; 14(11).
PMID: 39595571
PMC: 11591731.
DOI: 10.3390/biom14111394.
A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma.
Wu P, Fish M, Hazard F, Zhu C, Vennam S, Walton H
Nat Commun. 2024; 15(1):10007.
PMID: 39567523
PMC: 11579301.
DOI: 10.1038/s41467-024-53802-4.
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.
Kluiver T, Lu Y, Schubert S, Kraaier L, Ringnalda F, Lijnzaad P
Nat Commun. 2024; 15(1):8576.
PMID: 39567475
PMC: 11579375.
DOI: 10.1038/s41467-024-52757-w.
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma.
Demir S, Hotes A, Schmid T, Cairo S, Indersie E, Pisano C
J Exp Clin Cancer Res. 2024; 43(1):299.
PMID: 39529166
PMC: 11556140.
DOI: 10.1186/s13046-024-03221-6.
SerpinB3: A Multifaceted Player in Health and Disease-Review and Future Perspectives.
Cagnin S, Pontisso P, Martini A
Cancers (Basel). 2024; 16(14).
PMID: 39061218
PMC: 11274807.
DOI: 10.3390/cancers16142579.
Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers.
Gulati R, Fleifil Y, Jennings K, Bondoc A, Tiao G, Geller J
Cancers (Basel). 2024; 16(13).
PMID: 39001363
PMC: 11240720.
DOI: 10.3390/cancers16132300.
Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective.
Liang Y, Guo G, Zhang L
Gene Expr. 2024; 21(1):9-19.
PMID: 38911667
PMC: 11192043.
DOI: 10.14218/gejlr.2022.00010.
Aberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors.
Nishikawa Y
Pathol Int. 2024; 74(7):361-378.
PMID: 38837539
PMC: 11551836.
DOI: 10.1111/pin.13441.
Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L, Hasenfuss S, Guio-Carrion A, Thomsen M, Hasselblatt P, Wagner E
Proc Natl Acad Sci U S A. 2024; 121(18):e2404188121.
PMID: 38657045
PMC: 11067056.
DOI: 10.1073/pnas.2404188121.
First Transcriptome Analysis of Hepatoblastoma in Brazil: Unraveling the Pivotal Role of Noncoding RNAs and Metabolic Pathways.
Aguiar T, Rivas M, Silva E, Pires S, Dangoni G, Macedo T
Biochem Genet. 2024; .
PMID: 38649558
DOI: 10.1007/s10528-024-10764-y.
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.
Roehrig A, Hirsch T, Pire A, Morcrette G, Gupta B, Marcaillou C
Nat Commun. 2024; 15(1):3031.
PMID: 38589411
PMC: 11001886.
DOI: 10.1038/s41467-024-47280-x.
Summary of biological research on hepatoblastoma: a scoping review.
Wang H, Lao J, Jiang R, Wang B, Ma X, Wang J
Front Pediatr. 2024; 12:1309693.
PMID: 38390281
PMC: 10881832.
DOI: 10.3389/fped.2024.1309693.
Wnt/β-catenin signaling pathway in liver biology and tumorigenesis.
Matsumoto S, Kikuchi A
In Vitro Cell Dev Biol Anim. 2024; 60(5):466-481.
PMID: 38379098
DOI: 10.1007/s11626-024-00858-7.
DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
Sanceau J, Poupel L, Joubel C, Lagoutte I, Caruso S, Pinto S
Mol Ther. 2024; 32(4):1125-1143.
PMID: 38311851
PMC: 11163201.
DOI: 10.1016/j.ymthe.2024.01.036.